4 Year Metrics
Over the past four years, the reproductive healthcare industry has undergone a significant period of growth and expansion due to increased acceptance of and demand for fertility services from a wider range of people. Throughout this time, Monash IVF Group has remained at the forefront of our field and achieved consistently strong results across numerous key metrics.
No. of Specialists who joined MVF Group
25
No. of specialists at MVF Group
153
Average NPS Score
71
Employee Engagement Culture of Success
64%
Group clinical pregnancy rate for women aged <43 years
(per embryo transferred)
38.7%2023 Jan-Mar
New Patient Registrations
8,241+ 12%
Market Share
Key markets: Vic, NSW, QLD, SA & NT
22.7%
Group Revenue
$213.6m+ 11.1%
Underlying1, 2, 3 NPAT
$25.5m+ 14.7%
Underlying1, 2, 3 EBITDA
$53.4m+ 11%
Underlying1, 2, 3 EBIT
$38.1m+ 14.2%
Reported4 NPAT
$22m+ 18.9%
7
11
6
130
123
121
66
57
54
61%
61%
53%
38%
37%
36.4%
7,376+ 4% FY21
7,098+ 35% FY20
5,261- 11% FY19
21.3%
21.0%
20.4%
$192.3m+ 4.7% FY21
$183.6m+ 26.3% FY20
$145.4m- 4.3% FY19
$22.2m- 4.7% FY21
$23.3m+ 61.5% FY20
$14.4m- 31.2% FY19
$48.1m+ 0.8% FY21
$47.8m+ 37.4% FY20
$34.8m- 8% FY19
$33.4m- 5% FY21
$35.1m+ 43.9% FY20
$24.4m- 25.3% FY19
$18.5m- 28% FY21
$25.7m+ 117.8% FY20
$11.8m- 40.8% FY19
1. Non-IFRS measure. 2. Refer to page 32 for reconciliation of Reported EBITDA, EBIT and NPAT to Underlying EBITDA, EBIT and NPAT.
3. NPAT including minority interest. 4. Free Cash Flow is Net Operating cash flow (post-tax) less Cash Flow from investing activities.
5. Including capitalised bank fees